Evolving biological associations of upfront cytoreductive nephrectomy in metastatic renal cell carcinoma-Reference-Cited by-同舟云学术

Evolving biological associations of upfront cytoreductive nephrectomy in metastatic renal cell carcinoma

Published:2021-07-19 Issue:21 Volume:127 Page:3946-3956
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Silagy Andrew W.¹²^ORCID,Kotecha Ritesh R.³^ORCID,Weng Stanley¹⁴,Holmes Arturo⁴,Singla Nirmish¹^ORCID,Mano Roy¹,Attalla Kyrollis¹,Weiss Kate L.¹,DiNatale Renzo G.¹,Patil Sujata⁵,Coleman Jonathan A.¹,Motzer Robert J.³^ORCID,Russo Paul¹,Voss Martin H.³^ORCID,Hakimi A. Ari¹

Affiliation:

1. Urology Service, Department of Surgery Memorial Sloan Kettering Cancer Center New York New York

2. Department of Surgery University of MelbourneAustin Hospital Melbourne Victoria Australia

3. Department of Medicine Memorial Sloan Kettering Cancer Center New York New York

4. Department of Urology State University of New York Downstate New York New York

5. Epidemiology and Biostatistics Memorial Sloan Kettering Cancer Center New York New York

Funder

National Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.33790

Reference30 articles.

1. The Evolving Landscape of Metastatic Renal Cell Carcinoma

2. The difficulty in selecting patients for cytoreductive nephrectomy: An evaluation of previously described predictive models

3. Personalized Management of Advanced Kidney Cancer

4. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial

5. Nephrectomy Followed by Interferon Alfa-2b Compared with Interferon Alfa-2b Alone for Metastatic Renal-Cell Cancer

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the Prognostic Variables for Overall Survival in Patients with Metastatic Renal Cell Carcinoma: A Meta-Analysis Of 29,366 Patients;JU Open Plus;2024-04

2. Editorial Comment: Evaluating the Prognostic Variables for Overall Survival in Patients With Metastatic Renal Cell Carcinoma: A Meta-Analysis of 29,366 Patients;JU Open Plus;2024-04

3. Beyond the knife: strategic patient selection for cytoreductive nephrectomy;Current Opinion in Urology;2024-01-18

4. Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma;Scientific Reports;2024-01-17

5. Surgical outcomes of cytoreductive nephrectomy in patients receiving systemic immunotherapy for advanced renal cell carcinoma;Urologic Oncology: Seminars and Original Investigations;2023-12